DrugMapper
Browse
Therapeutic Area
CANCER (51)
CARDIOVASCULAR (45)
DENTISTRY (2)
DERMATOLOGY (31)
DIABETES DRUGS & ENDOCRINOLOGY (61)
EMERGENCY MEDICINE (3)
ENT (5)
EYE (23)
GASTROINTESTINAL (29)
HEMATOLOGY (23)
MUSCULOSKELETAL (28)
NEUROLOGY DRUGS & NERVOUS SYSTEM (50)
PEDIATRICS (27)
PHARMACOLOGY (8)
PREGNANCY AND GYNECOLOGY (30)
RESPIRATORY (42)
RHEUMATOLOGY (19)
OTHER (1482)
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Primary Target
Target Level
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Active Pharmaceutical Ingredients (APIs)
Small Molecules
ProDrugs
Antibodies
CNS drugs
Metabolites
Search
Therapeutic Indication
Adverse Reaction (System Organ Classification)
Mechanism of Action
Target Sequence
Chemical Structure
Physicochemical Properties
Analyze
Networks
Chemical Similarity
Scaffold Similarity
KNIME workflow
Downloads
Web services
Bulk Downloads
About
DrugMapper FAQs
Data Sources
Contact Us
HYDRALAZINE HYDROCHLORIDE; HYDROCHLOROTHIAZIDE; RESERPINE
Search structure
Trade Names:
CAM-AP-ES
HYDRALAZINE HYDROCHLORIDE, HYDROCHLOROTHIAZIDE AND RESERPINE
HYDRALAZINE HYDROCHLORIDE-HYDROCHLOROTHIAZIDE-RESERPINE
HYDRALAZINE, HYDROCHLOROTHIAZIDE W/ RESERPINE
HYDRAP-ES
HYDROCHLOROTHIAZIDE W/ RESERPINE AND HYDRALAZINE
HYDROSERPINE PLUS (R-H-H)
RESERPINE, HYDRALAZINE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE
RESERPINE, HYDROCHLOROTHIAZIDE, AND HYDRALAZINE HYDROCHLORIDE
SER-A-GEN
SER-AP-ES
UNIPRES
Status:
Approved
Entry Type:
Combination
Molecule Category:
Mixture
Compounds in the Mixture:
HYDRALAZINE HYDROCHLORIDE
HYDROCHLOROTHIAZIDE
RESERPINE
Related Entries
Salt
HYDRALAZINE HYDROCHLORIDE
Parent
HYDROCHLOROTHIAZIDE
Parent
RESERPINE
Adverse Reactions
SOC By Demographic Distribution
System Organ Classification (SOC)
Relative Frequency (%)
Nervous system disorders
22.22
Skin and subcutaneous tissue disorders
16.67
Investigations
11.11
Psychiatric disorders
11.11
Respiratory, thoracic and mediastinal disorders
11.11
Vascular disorders
11.11
Cardiac disorders
5.56
General disorders and administration site conditions
5.56
Immune system disorders
5.56
CONTENTS
Structure
Related Entries
Adverse Reactions
×
Active Pharmaceutical Ingredients (APIs)
Scaffolds
Exact
Similarity
SubStructure
Threshold (%) >=
70